3 Dividend Stocks to Buy for a Lifetime of Passive Income
Key Points Novartis is expertly handling massive patent cliffs, which speaks volumes about how resilient its business is.…
Global Refiners Are Cutting Out Oil Traders To Buy Venezuelan Crude Directly
Commodity traders are having the rug pulled out from under one of their biggest paydays yet as refiners…
Chubb Trades at Just 12 Times Earnings, Well Below the Broader Market. Is One of the World’s Biggest Insurers a Bargain?
Chubb(NYSE: CB), the world’s largest publicly traded provider of property, supplemental health, and casualty insurance, is a reliable…
Are Biosimilars Becoming a Key Pillar of Amgen’s Growth Story?
Historically known for its innovative biologic medicines such as Enbrel, Prolia and Repatha, AmgenAMGN has also emerged as…
Chart of the Day: The “IPO Overload” Counterargument
I dropped a MoneyShow Video Market Minute on Friday about the “IPO Overload” – a scenario where the…
VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition
Investor Brand Network – Tue Jul 7, 10:35AM CDT Novartis has agreed to acquire Myricx Bio for $1.1 billion upfront, with up to…
VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition
Investor Brand Network – 1 hour ago Novartis has agreed to acquire Myricx Bio for $1.1 billion upfront, with up to $400 million…
VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition
Investor Brand Network – 44 minutes ago Novartis has agreed to acquire Myricx Bio for $1.1 billion upfront, with up to $400 million…
Why Illumina (ILMN) Stock Is Down Today
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche…
Chubb vs. Travelers Companies: What Their Revenue Trends Tell Investors
Key Points Chubb currently generates consistently higher revenue than Travelers Companies. Over the past eight quarters, Chubb exhibited…
FDA Accepts Roche’s Filing for Lunsumio VELO-Polivy in LBCL
Roche RHHBY announced that the FDA has accepted its supplemental biologics license application (sBLA) seeking approval of Lunsumio…
Why Tesla Stock Dropped on Tuesday
Tesla (NASDAQ: TSLA) stock tumbled 6%.1 through 3:15 p.m. ET Tuesday, one week before Tesla is expected to…